Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sohm Inc (OP: SHMN )

0.0010 UNCHANGED
Streaming Delayed Price Updated: 11:28 AM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Sohm Inc

< Previous 1 2 3 Next >
Study Shows Patients Afflicted by Inflammatory Arthritis Face Numerous Mental Challenges at Work
Via Investor Brand Network
BioMedNewsBreaks – SOHM Inc. (SHMN) Unveils New Suite of SOHM Nutrients’ Brand Chewables
Via Investor Brand Network
SOHM OTC Self-care Launches Suite of 13 New SOHM Nutrients’ Brand Chewables
From SOHM, Inc.
Via GlobeNewswire
SOHM Inc. Announces the Closure of Finances-Funding for its Various Projects
Via ACCESSWIRE
SOHM Inc. Signed an Exclusive Distribution Agreement with India-based Stallion Laboratories Pvt. Ltd. for Levetiracetam for the Treatment of Epilepsy
Via ACCESSWIRE
BioMedNewsBreaks – SOHM Inc.’s (SHMN) ABBIE Technology Poised to Make a Difference in the Lives of Millions
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Meta-Analysis Says Nutraceuticals Show Potential in Acne Treatment
Via Investor Brand Network
SOHM, Inc. (SHMN) Completes Acquisition of ABBIE Gene-editing Tech, Begins Preparations to Commercialize Solutions for Heart Disease
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
SOHM, Inc. (SHMN) Bolsters Executive Team; Confident About Anticipated Developments and Opportunities
Via Investor Brand Network
BioMedNewsBreaks – SOHM, Inc. (SHMN), UACI Collaborate to Advance ABBIE, a Groundbreaking Non-Viral Gene-Editing Technology
Via Investor Brand Network
SOHM Collaborates with University of Arizona Center for Innovation to Advance ABBIE, a Groundbreaking Non-Viral Gene-Editing Technology
From SOHM, Inc.
Via GlobeNewswire
BioMedNewsBreaks – SOHM, Inc. (SHMN) Announces Acquisition of World-Class Gene-Editing Platform
Via Investor Brand Network
SOHM Announces Its Acquisition of ABBIE, a World-Class Gene-Editing Platform Which Can Deliver Genetic Payloads Using Non-Viral Vectors
From SOHM, Inc.
Via GlobeNewswire
BioMedNewsBreaks — SOHM Inc. (SHMN) Expands Team to Direct Global Growth Strategy
Via Investor Brand Network
Generic Drug Manufacturer SOHM, Inc. (SHMN) Building Regenerative Medicine Platform with LOI for Gene Editing Technology
Via Investor Brand Network
Topics Economy
Exposures Supply Chain
Leadership Changes At SOHM, Inc. (SHMN) to Strengthen Growth Strategies for Generic Drug Market and Gene Editing Platform Development
Via Investor Brand Network
BioMedNewsBreaks – SOHM Inc. (SHMN) Names Seasoned Veteran as VP of Quality
Via Investor Brand Network
SOHM, Inc. Announces the Appointment of Wm. Dewey Rushing as VP of Quality with Immediate Effect
From SOHM, Inc.
Via GlobeNewswire
BioMedNewsBreaks – SOHM, Inc. (SHMN) Announces Strategic Board Appointment of Dr. Krishna Bhat, MD, Ph.D., FACC
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
SOHM, Inc. Expands Its Advisory Board, Appointing Dr. Krishna Bhat, M.D, Ph.D., FACC, as Chief Medical Advisor
From SOHM, Inc.
Via GlobeNewswire
SOHM, Inc. Announce the Appointment of Dr. David Aguilar, Ph.D. as a Chief Operating Officer with the Company with Immediate Effect
Via ACCESSWIRE
SOHM Inc. Signs LOI to Acquire Stem Cell Disruptive Technology and Patents
Via ACCESSWIRE
SOHM, Inc. Introduces and Received Topical Skincare Line of Products Orders in Its Label
Via ACCESSWIRE
SOHM, Inc. Signs MOU with London/Asia-Based Fund to Infuse Funds for Various Projects
Via ACCESSWIRE
SOHM, Inc. Expands Advisory Board with Appointment of Dr. David Aguilar Ph.D., as its Expert Medical Advisor.
CHINO HILLS, CA / ACCESSWIRE / March 2, 2022 / SOHM, Inc. (OTC PINK:SHMN), a Pharmaceutical, Nutraceutical, and Cosmeceutical company that manufactures and markets generic drugs covering numerous... 
From SOHM, Inc.
Via AccessWire
SOHM, Inc. Announces the Appointment of Wm. Dewey Rushing, former US FDA Investigator to its Advisory Board
CHINO HILLS, CA / ACCESSWIRE / February 23, 2022 / SOHM, Inc. (OTC PINK:SHMN), a Pharmaceutical, Nutraceutical, and Cosmeceutical company that manufactures and markets generic drugs covering numerous... 
From SOHM, Inc.
Via AccessWire
Exposures Product Safety
SOHM, Inc., Collaborates for Commercial Manufacturing of Brainwise(R), a Patented Omega 3 Formula for Global Distribution
This collaboration expands SOHM, Inc's manufacturing, and distribution footprint into Africa with an estimated $7,500,000 in revenue over 3 years. CHINO HILLS, CA / ACCESSWIRE / November 30, 2021 /... 
From SOHM, Inc.
Via AccessWire
SOHM, Inc. Signs Industry Expert Sivana Group as Strategic Consultant for Rebranding and Global Expansion
SOHM, Inc. takes a step forward in achieving maximum value for their organizations' stakeholders with strategic rebranding and global expansion CHINO HILLS, CA / ACCESSWIRE / November 15, 2021 / SOHM,... 
From SOHM, Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
SOHM, Inc., Announces Important Details of Its California Pharmaceutical Company Acquisition Expanding Manufacturing into the US Market
Expanding SOHM, Inc's Pharmaceutical manufacturing capabilities under FDA licensing opens new opportunities for OTC, Cosmeceuticals, Veterinary, and Prescription Rx. CHINO HILLS, CA / ACCESSWIRE /... 
From SOHM, Inc.
Via AccessWire
Exposures Product Safety
SOHM, Inc., Signed a Definitive Agreement for Acquisition of Californian Pharmaceutical Company
SOHM, Inc. has taken a step forward in establishing its manufacturing base and network in the USA CHINO HILLS, CA / ACCESSWIRE / September 30, 2021 / SOHM, Inc. (OTC PINK:SHMN), a generic... 
From SOHM, Inc.
Via AccessWire
Exposures Product Safety
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.